Evidence map›Paper›PMID 40247865›Full record

Observational studyFrontiers in public health2025

Impact of medication use on olfactory performance in older adults.

Maite Izco-Cubero, Fabiola Zambom-Ferraresi, Fabricio Zambom-Ferraresi, María Luisa Fernández González de la Riva, Enrique Santamaría, Joaquín Fernandez-Irigoyen, Mercedes Lachén-Montes, Juan Jose Lasarte, Maria Uzcanga-Lacabe, Secundino Fernandez and 3 more

Abstract readObservational Study
In one paragraph

Observational study in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Maite Izco-CuberoGeriatrics and Active Aging Research Group (INGEA), Navarrabiomed, Pamplona, Navarra, Spain.
Fabiola Zambom-FerraresiGeriatrics and Active Aging Research Group (INGEA), Navarrabiomed, Pamplona, Navarra, Spain.
Fabricio Zambom-FerraresiGeriatrics and Active Aging Research Group (INGEA), Navarrabiomed, Pamplona, Navarra, Spain.
María Luisa Fernández González de la RivaGeriatrics and Active Aging Research Group (INGEA), Navarrabiomed, Pamplona, Navarra, Spain.
Enrique SantamaríaUniversidad Pública de Navarra (UPNA), Pamplona, Navarra, Spain.
Joaquín Fernandez-IrigoyenUniversidad Pública de Navarra (UPNA), Pamplona, Navarra, Spain.
Mercedes Lachén-MontesClinical Neuroproteomics, Navarrabiomed, Pamplona, Navarra, Spain.
Juan Jose LasarteIdiSNA, Pamplona, Navarra, Spain.
Maria Uzcanga-LacabeUniversidad Pública de Navarra (UPNA), Pamplona, Navarra, Spain.
Secundino FernandezOtorhinolaryngology Department, Clínica Universidad de Navarra (CUN), Pamplona, Navarra, Spain.
Gloria Sanjurjo San MartinCentro Sociosanitario Bidealdea, Cizur Menor, Navarra, Spain.
Enrique Maraví-AznarUniversidad Pública de Navarra (UPNA), Pamplona, Navarra, Spain.
Nicolas Martinez-VelillaGeriatrics and Active Aging Research Group (INGEA), Navarrabiomed, Pamplona, Navarra, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Olfactory dysfunction impacts quality of life, safety, and nutrition. Despite its relevance among older adults, the role of medications in influencing olfactory performance remains understudied. This research investigates whether olfactory alterations in older adults are associated with the type or number of medications prescribed. Methods: An observational cross-sectional study was conducted with 107 participants (mean age of 86.1 ± 5.1 years). Olfactory performance was evaluated using the Sniffin' Sticks Test (SST). Functional capacity, cognitive function and the number and type of medications were also assessed. Results: The analysis demonstrated a correlation between better olfactory performance and higher cognitive function. An inverse correlation was found between the age of participants and olfactory identification. While polypharmacy (intake of five or more medications) did not show a significant association with olfactory dysfunction, the intake of laxatives was associated with poorer olfactory threshold performance (-1.21, 95% CI -2.07 to -0.34; Discussion: These findings suggest that certainmedications influence olfactory performance; however, further research is needed to clarify the effects of different drug classes on olfaction.

Indexed as

Olfaction DisordersSmellAgedAged, 80 and overCognitionCross-Sectional StudiesFemaleHumansMalePolypharmacyQuality of Lifeageingmedicationolder peopleolfactionolfactory disordersolfactory dysfunctionpolypharmacy

Identifiers

PMID40247865
PMCPMC12003291

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.